Aurinia Pharmaceuticals
AUPH
AUPH
67 hedge funds and large institutions have $107M invested in Aurinia Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
6% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 18
59% less call options, than puts
Call options by funds: $1M | Put options by funds: $2.42M
Holders
67
Holding in Top 10
–
Calls
$1M
Puts
$2.42M
Top Buyers
| 1 | +$3.33M | |
| 2 | +$2M | |
| 3 | +$833K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$650K |
| 5 |
Franklin Resources
San Mateo,
California
|
+$387K |
Top Sellers
| 1 | -$2.99M | |
| 2 | -$2.58M | |
| 3 | -$2.18M | |
| 4 |
D.E. Shaw & Co
New York
|
-$660K |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$394K |